Roche Holding AG hopes that China will be its top 3 global market by 2015, up from 10th last year, said chairman Franz Humer during a visit to China.
The Swiss pharmaceutical company, one of the largest of its kind in the world, has recently announced a plan to spend ¥450 million building a research and development center in suburban Shanghai's Zhangjiang area, increasing its total investment in China to ¥1.4 billion. Roche relocated its Asia Pacific headquarters to Shanghai in 2009. Its business in China currently concentrates on the top ranking hospitals and should expand down further as the government's healthcare reform is to benefit smaller hospitals and community clinics, said Roche China president Chen Peiqian.
Aucun commentaire:
Enregistrer un commentaire